🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of tis study is to assess the efficacy and safety of Jarsin® 300 mg...
Status
Completed
Location
Multiple Locations
Start Date
2002-12
Trial ID
NCT00861978
Treatments Being Tested
A randomized, double-blind, phase II clinical trial was conducted versus pl...
Status
Completed
Location
Gastroenterology Institute
Start Date
2015-10-15
Trial ID
NCT03584308
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
The research will be prospective, randomised, placebo controlled and double...
Status
Unknown
Location
Department of Radiotherapy and Oncology
Start Date
2018-02-09
Trial ID
NCT03705442
Treatments Being Tested
The goal of this clinical trial is to investigate the local delivery of min...
Status
Completed
Location
Enas Elgendy
Start Date
2023-05-20
Trial ID
NCT06997731
Venous thromboembolism is a frequent issue in severe trauma patients. Guide...
Status
Not Yet Recruiting
Location
CHU Angers
Start Date
2026-04
Trial ID
NCT07506473
Treatments Being Tested
MAD0004J08, the experimental drug, is a potent neutralizing IgG1 monoclonal...
Status
Unknown
Location
IRCCS INMI Lazzaro Spallanzani - Istituto nazionale Malattie Infettive
Start Date
2021-06-06
Trial ID
NCT04952805
Treatments Being Tested
Post-meal low blood sugar (postprandial hypoglycemia) is a common problem a...
Status
Not Yet Recruiting
Location
Kantonsspital Olten
Start Date
2026-07
Trial ID
NCT07580079
Treatments Being Tested
This is a Phase 3, randomized, double-blind, placebo-controlled study to ev...
Status
Completed
Location
Neurocrine Clinical Site
Start Date
2019-11-13
Trial ID
NCT04102579
Treatments Being Tested